CPT code 20225 represents a percutaneous deep bone biopsy performed with a needle or trocar to obtain bone tissue for laboratory analysis. This procedure is clinically important for diagnosing bone infections, primary or metastatic malignancies, and certain metabolic or infiltrative bone disorders. Nationally, the code captures imaging- and procedure-dependent work that typically occurs in hospital outpatient departments, inpatient settings, and ambulatory surgery centers.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage considerations, common billing modifiers, and operational benchmarks relevant to facilities and clinicians who perform deep bone biopsies.

Readers will find: an explanation of the clinical context and service setting for CPT code 20225; typical site-of-service and resource implications; an overview of common modifiers used for procedural billing; and a summary of what to expect from major payers and Medicare regarding claim processing and documentation expectations. Data not available in the input is noted where applicable.